Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–164 of 164 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Chronic Neuropathic Pain Clear all

Conditions: Pain
Interventions: GSK3858279, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 19
States / cities: Anniston, Alabama • Surprise, Arizona • Cerritos, California + 15 more

Conditions: Back Pain, Back Pain With Radiation, Pain in Leg, Unspecified
Interventions: Sub-Sensory Stimulation; Other
Lead sponsor: Algos Clinical Development Thomas L. Yearwood, MD, PhD; Other
Eligibility: 22 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Pascagoula, Mississippi

Conditions: Central Neuropathic Pain, Allodynia, Spinal Cord Injury
Interventions: Dextromethorphan; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neuropathic Pain, Chronic Pain, Multiple Sclerosis
Interventions: Lidocaine patch 5%, Extended-release oxycodone, Placebo extended-release oxycodone pills, Placebo lidocaine patches; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Pain, Neuropathic, Failed Back Surgery Syndrome
Interventions: Coordinated Reset spinal cord stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 22 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chronic Pain, Neuropathic Pain, Failed Back Surgery Syndrome, Complex Regional Pain Syndromes
Interventions: HD Study Electrode; Device
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Albany, New York

Conditions: Neuropathic Pain
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Neuropathic Pain, Chronic Pain
Interventions: Scrambler Therapy MC-5A Device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 5 Years to 26 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pain, Low Back Pain, Osteoarthritis, Neuropathic Pain
Interventions: BEMA Buprenorphine; Drug
Lead sponsor: BioDelivery Sciences International; Industry
Eligibility: 18 Years and older
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 26
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 23 more

Conditions: Head and Neck Cancer
Interventions: Questionnaires, Quantitative Sensory Testing; Behavioral · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 838 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 2
States / cities: Houston, Texas

Conditions: Neuropathic Pain, Distal Sensory Polyneuropathy
Interventions: LY3848575, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 24
States / cities: Chandler, Arizona • Phoenix, Arizona • Fresno, California + 20 more

Conditions: Pain, Pain, Acute, Pain, Chronic, Pain, Neuropathic, Opioid-use Disorder, Opioid Abuse and Addiction, Opioid Withdrawal
Interventions: Quality IQ Patient Simulations; Other
Lead sponsor: Qure Healthcare, LLC; Industry
Eligibility: Not listed
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Back Pain, Lower Back Pain, Cervical Pain
Interventions: Naltrexone and Clonidine Combination, placebo; Drug
Lead sponsor: Annette C. Toledano MD; Industry
Eligibility: 19 Years to 70 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: North Miami, Florida

Conditions: Postherpetic Neuralgia, Pain
Interventions: V116517 50-mg tablets, V116517 30-mg tablets, Pregabalin capsules, Placebo; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 21 Years to 90 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 28
States / cities: Tucson, Arizona • La Jolla, California • North Hollywood, California + 25 more

Conditions: Failed Back Surgery Syndrome
Interventions: Subdural trial lead, Epidural trial lead; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain
Interventions: Oxymorphone; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Neuralgia Peripheral, Pain
Interventions: Gabapentin, BTACT, BPI, HADS, SLP9, NPSI; Drug · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 3 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Endometriosis Related Pain, Overactive Bladder, Diabetic Neuropathic Pain, Refractory or Unexplained Chronic Cough
Interventions: BAY1817080; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Miami, Florida • Orlando, Florida

Conditions: Diabetic Peripheral Neuropathic Pain
Interventions: LY3556050, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 35
States / cities: Chandler, Arizona • Glendale, Arizona • Tempe, Arizona + 28 more

Conditions: Chronic Pelvic Pain, Pudendal Neuralgia
Interventions: Saluda Evoke Smart SCS System; Device
Lead sponsor: Ainsworth Institute of Pain Management; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Sub-Sensory Intraspinal Neurostimulation Therapy

Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial

Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis

Coordinated Reset Spinal Cord Stimulation

Intraoperative Neuromonitoring Recording With a Novel SCS Paddle

Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study

Pediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain

Neuropathic Pain in Head and Neck Cancer

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

Assessing Opioid Care Practices Using CPV Patient Simulation Modules

Naltrexone and Clonidine Combination (ATNC05) in the Treatment of Chronic Back Pain

Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)

Clinical Evaluation of Direct Dorsal Column Stimulation

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)

Cognitive Changes With Gabapentin Treatment

Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain

Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial